FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹318 Cr | ₹221 Cr | ₹155 Cr | ₹162 Cr | ₹207 Cr |
What is the latest Cash Flow from Operating Activities ratio of FDC ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹155 Cr |
| Mar2022 | ₹162 Cr |
| Mar2021 | ₹207 Cr |
How is Cash Flow from Operating Activities of FDC Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 43.85 | |
| Mar2024 | ₹221 Cr | 42.51 | |
| Mar2023 | ₹155 Cr | -4.17 | |
| Mar2022 | ₹162 Cr | -21.94 | |
| Mar2021 | ₹207 Cr | - | |
Compare Cash Flow from Operating Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,475.8 Cr | -2.2% | -18% | -27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -2.2% |
-18% |
-27.1% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses